Fostering open collaboration in drug development for paediatric brain tumours

Wong et al. describe in Biochemical Society Transactions how open collaboration and an open drug discovery model, like the one used by M4K Pharma, can help overcome the challenges faced while researching therapies for rare paediatric brain tumours such as DIPG. 

Prognosis of childhood brain tumours (from: http://www.biochemsoctrans.org/content/early/2019/09/23/BST20190315)